MoneyWorks4Me

Neuland Laboratories - Quaterly Results

07 Nov 2023 Evaluate
The Sales for the quarter ended September 2023 of Rs. 4177.49 millions rose by 42.23% from Rs. 2937.06 millions.The Net Profit of the company vaulted to 132.34% to Rs. 890.65  millions from Rs. 383.34 millions in the previous quarter.OP of the company witnessed a marginal growth to 1403.46 millions from 694.09 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 4177.49 2937.06 42.23 7807.43 5148.76 51.64 11911.98 9510.77 25.25
Other Income 30.48 2.39 1175.31 50.87 7.51 577.36 97.48 20.77 369.33
PBIDT 1403.46 694.09 102.20 2396.50 983.99 143.55 2810.56 1442.71 94.81
Interest 44.33 31.75 39.62 66.47 60.33 10.18 130.67 134.94 -3.16
PBDT 1359.13 662.34 105.20 2330.03 923.66 152.26 2679.89 1307.77 104.92
Depreciation 145.08 131.72 10.14 280.94 259.70 8.18 527.76 490.36 7.63
PBT 1214.05 530.62 128.80 2049.09 663.96 208.62 2152.13 817.41 163.29
TAX 323.40 147.28 119.58 536.20 182.21 194.28 520.94 182.06 186.14
Deferred Tax 9.03 3.96 128.03 12.36 -2.11 -685.78 17.04 -22.16 -176.90
PAT 890.65 383.34 132.34 1512.89 481.75 214.04 1631.19 635.35 156.74
Equity 129.01 129.01 0.00 129.01 129.01 0.00 129.01 129.01 0.00
PBIDTM(%) 33.60 23.63 42.16 30.70 19.11 60.61 23.59 15.17 55.54
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..